Skip to page content

New patent sales agreement between BayPAT and Reactive Robotics

Jul 6, 2022

MedTech made in Munich

Munich, Germany, July 6th, 2022 – BayPAT, service provider offering services in the area of technology transfer, IP management and commercialization, today announced that it has entered into a patent purchase agreement with Reactive Robotics GmbH. The patented technology was developed at the Technical University of Munich in cooperation with the company and is relevant for the early mobilization of patients after acute neurological diseases.

According to studies, early mobilization of patients after a stroke or traumatic brain injury can contribute to an accelerated recovery process and to regaining independence. Difficulties in performing mobilization exercises include quick fatigue and carrying out unpredictable movements. Furthermore, early mobilization is associated with high physical effort and precious time for the nursing staff in the clinical routine.

This is where the product “VEMOTION” from Reactive Robotics GmbH comes in. VEMOTION supplements manual therapy with an adaptive robotic assistance system and supports nursing staff and therapists in mobilizing their patients. This product implements the above-mentioned invention to provide customized support to patients according to their progress and their own physical abilities. Therefore, the technology benefits both patients and caregivers. Many years of experience in the field of robotic applications in medical technology united in the team of inventors from the Technical University of Munich contributed significantly to the development of this technology.

BayPAT negotiated the patent purchase agreement with a selected team of experts and thus set the course for the successful transfer of the innovation into industrial applications. "This is another example of how the results of academic research projects can positively influence everyday life and the quality of life for everyone," said Dr. Robert Phelps, Managing Director of BayPAT.

About BayPAT

Bayerische Patentallianz GmbH (BayPAT) was founded in 2007 by the Universities of Bavaria e.V. and the Bavarian Universities of Applied Sciences e.V. as central patent and marketing agency to foster technology transfer of the Bavarian research landscape and cares for 33 research institutes. Under the umbrella of the Bavarian Research and Innovation Agency (BayFIA), BayPAT is a full-service technology management provider offering services in the area of technology transfer, intellectual property (IP) management and commercialization. Key clients are the Bavarian Universities, University Hospitals and Universities of Applied Sciences and its over 25.000 associated scientists, as well as non-university research institutes, industry, and independent inventors worldwide. Main focus in assessing and exploiting IP are the areas of biotechnology, chemistry, medical engineering, physics, automotive industry, energy and environmental engineering, information and communication technology as well as mechanical engineering.


Dr. Robert Phelps, Managing Director
Bayerische Patentallianz GmbH
Prinzregentenstr. 52
80538 München
Tel. +49 (0)89 54801770

About Reactive Robotics GmbH

Reactive Robotics was founded in April 2015 in Munich with the goal of providing the best possible early mobilization for critically ill intensive care patients. The team around the founder, Dr. Alexander König, received the CE approval for their robotic assistance system VEMOTION in 2019. Since 2020, the company's robots have been providing therapy to severely affected patients in various hospitals. In 2021, the team was awarded the prestigious euRobotics Tech Transfer Award 2021 together with the development partners of the Technical University of Munich and the Schön Klinik Bad Aibling.


Dr. Alexander König, CEO
Reactive Robotics GmbH
Landsbergerstr. 234
80687 München
phone +49 (0)89 960403300

Your contact:

Interested? Get in touch!

Contact a specific team member via the Team section or simply use our contact form for your request.

Privacy settings

This website uses cookies. Cookies improve its usage and help make this website better.
Privacy policy